general
Dr. Richard Gorlick, MD – Houston, TX
Written by Grace Evans — 0 Views
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients with Osteosarcoma
Richard Gorlick, MD, JAMA OncologyFuture directions in the treatment of osteosarcoma
Bishop MW, Janeway KA, Gorlick R, Curr Opin Pediatr, 1/1/2016Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma
Yang R, Piperdi S, Zhang Y, Zhu Z, Neophytou N, Hoang BH, Mason G, Geller D, Dorfman H, Meyers PA, Healey JH, Phinney DG, Gorlick R, Clin Orthop Relat Res, 1/1/2016
